Vanbever R - Search Results

1

Needle-free iontophoresis-driven β-adrenergic sweat rate test.

Reynaerts A, Vermeulen F, Mottais A, Gohy S, Lebecque P, Frédérick R, Vanbever R, Leal T. Reynaerts A, et al. Among authors: vanbever r. J Cyst Fibros. 2022 May;21(3):407-415. doi: 10.1016/j.jcf.2021.08.012. Epub 2021 Sep 4. J Cyst Fibros. 2022. PMID: 34489187 Free article.

2

Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.

Lubamba B, Lebacq J, Lebecque P, Vanbever R, Leonard A, Wallemacq P, Leal T. Lubamba B, et al. Among authors: vanbever r. Am J Respir Crit Care Med. 2009 Jun 1;179(11):1022-8. doi: 10.1164/rccm.200901-0049OC. Epub 2009 Mar 19. Am J Respir Crit Care Med. 2009. PMID: 19299496

3

Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy.

Luo T, Magnusson J, Préat V, Frédérick R, Alexander C, Bosquillon C, Vanbever R. Luo T, et al. Among authors: vanbever r. Pharm Res. 2016 Jul;33(7):1671-81. doi: 10.1007/s11095-016-1908-2. Epub 2016 Mar 16. Pharm Res. 2016. PMID: 26984129

4

Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy.

Guichard MJ, Patil HP, Koussoroplis SJ, Wattiez R, Leal T, Vanbever R. Guichard MJ, et al. Among authors: vanbever r. Int J Pharm. 2017 May 30;524(1-2):159-167. doi: 10.1016/j.ijpharm.2017.03.057. Epub 2017 Mar 27. Int J Pharm. 2017. PMID: 28356227

5

Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.

Guichard MJ, Kinoo D, Aubriot AS, Bauwens N, Gougué J, Vermeulen F, Lebecque P, Leal T, Vanbever R. Guichard MJ, et al. Among authors: vanbever r. Clin Sci (Lond). 2018 Jul 18;132(13):1439-1452. doi: 10.1042/CS20180315. Print 2018 Jul 18. Clin Sci (Lond). 2018. PMID: 29871879

6

Activity of Antibiotics against Staphylococcus aureus in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.

Diaz Iglesias Y, Wilms T, Vanbever R, Van Bambeke F. Diaz Iglesias Y, et al. Among authors: vanbever r. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00602-19. doi: 10.1128/AAC.00602-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31036685 Free PMC article.

7

Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study.

Mahri S, Wilms T, Hagedorm P, Guichard MJ, Vanvarenberg K, Dumoulin M, Frijlink H, Vanbever R. Mahri S, et al. Among authors: vanbever r. Eur J Pharm Sci. 2023 Oct 1;189:106522. doi: 10.1016/j.ejps.2023.106522. Epub 2023 Jul 8. Eur J Pharm Sci. 2023. PMID: 37423579 Free article.

8

Performance-driven, pulmonary delivery of systemically acting drugs.

Vanbever R. Vanbever R. Drug Discov Today Technol. 2005 Spring;2(1):39-46. doi: 10.1016/j.ddtec.2005.05.016. Drug Discov Today Technol. 2005. PMID: 24981754

9

Transdermal delivery of metoprolol by electroporation.

Vanbever R, Lecouturier N, Préat V. Vanbever R, et al. Pharm Res. 1994 Nov;11(11):1657-62. doi: 10.1023/a:1018930425591. Pharm Res. 1994. PMID: 7870686

10

Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors.

Vanbever R, LeBoulengé E, Préat V. Vanbever R, et al. Pharm Res. 1996 Apr;13(4):559-65. doi: 10.1023/a:1016093920875. Pharm Res. 1996. PMID: 8710746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters